Hsieh JT - Search Results

1

PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.

Yeh HC, Margulis V, Singla N, Hernandez E, Panwar V, Woldu SL, Karam JA, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Li CC, Ke HL, Li WM, Lee HY, Rapoport LM, Lotan Y, Kapur P, Shariat SF, Hsieh JT, Wu WJ. Yeh HC, et al. Among authors: hsieh jt. Urol Oncol. 2020 May;38(5):496-505. doi: 10.1016/j.urolonc.2019.11.010. Epub 2019 Dec 18. Urol Oncol. 2020. PMID: 31862213

2

Molecular imaging in prostate cancer.

Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. J Cell Biochem. 2003 Oct 15;90(3):473-83. doi: 10.1002/jcb.10636. J Cell Biochem. 2003. PMID: 14523981 Review.

3

The application of epigenetic modifiers on the treatment of prostate and bladder cancer.

Zhang Z, Karam J, Frenkel E, Sagalowsky A, Hsieh JT. Zhang Z, et al. Among authors: hsieh jt. Urol Oncol. 2006 Mar-Apr;24(2):152-60. doi: 10.1016/j.urolonc.2005.11.004. Urol Oncol. 2006. PMID: 16520279 Review.

4

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Svatek RS, et al. Among authors: hsieh jt. Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795. Cancer. 2006. PMID: 16541433 Free article.

5

Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.

Lotan Y, Stanfield J, Cho LC, Sherwood JB, Abdel-Aziz KF, Chang CH, Forster K, Kabbani W, Hsieh JT, Choy H, Timmerman R. Lotan Y, et al. Among authors: hsieh jt. J Urol. 2006 May;175(5):1932-6. doi: 10.1016/S0022-5347(05)00893-1. J Urol. 2006. PMID: 16600801

6

Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.

Chen H, Karam JA, Schultz R, Zhang Z, Duncan C, Hsieh JT. Chen H, et al. Among authors: hsieh jt. DNA Cell Biol. 2006 Apr;25(4):232-45. doi: 10.1089/dna.2006.25.232. DNA Cell Biol. 2006. PMID: 16629596

7

Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.

Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, Lotan Y. Walsh L, et al. Among authors: hsieh jt. Eur Urol. 2006 Oct;50(4):795-800; discussion 800. doi: 10.1016/j.eururo.2006.03.021. Epub 2006 Mar 29. Eur Urol. 2006. PMID: 16632182

8

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. Int J Cancer. 2007 Apr 15;120(8):1795-802. doi: 10.1002/ijc.22405. Int J Cancer. 2007. PMID: 17230511 Free article.

9

Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.

Margulis V, Shariat SF, Ashfaq R, Thompson M, Sagalowsky AI, Hsieh JT, Lotan Y. Margulis V, et al. Among authors: hsieh jt. J Urol. 2007 Mar;177(3):1163-8. doi: 10.1016/j.juro.2006.10.033. J Urol. 2007. PMID: 17296438

10

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. Karam JA, et al. Among authors: hsieh jt. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6. doi: 10.1158/1078-0432.CCR-07-0287. Clin Cancer Res. 2007. PMID: 17671122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page